Portal embolization in various types of liver: Novel variables to predict hypertrophy

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 140-145

  Kaido, Toshimi ^a,c   Arii, Shigeki ^b   Shimada, Yutaka ^a   Mori, Akira ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OTSU MUNICIPAL HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Hypertrophy; Major hepatectomy; Portal embolization

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILIARY TRACT CANCER; CHRONIC HEPATITIS; FEMALE; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER RESECTION; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTE COUNT;

ADULT; AGED; BILIARY TRACT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; HYPERTROPHY; LIVER; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RECOVERY OF FUNCTION;

EID: 12244295470     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rous P, Larimore LD: Relation of the portal blood to liver maintenance; a demonstration of liver atrophy conditional on compensation. J Exp Med 1920; 31:609-632.
2. Ozawa K, Takasan H, Kitamura O, Mizukami T, Kamano T: Effect of ligation of portal vein in liver mitochondrial metabolism. J Biochem 1971; 70:755-764.
3. Kozaka S: Extensive hepatectomy in two stages. An experimental study. Arch Jpn Chir 1963; 32:99-123.
4. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S: Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10:803-808.
5. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527.
6. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, Moriya Y: Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994; 115:674-677.
7. Kutsuma Y, Hayakawa N, Yamamoto H: Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995; 117:677-687.
8. Takayama T, Makuuchi M, Kosuge T, Yamamoto J, Shimada K, Inoue K: Preoperative portal embolization. Ann Ital Chir 1997; 68:745-750.
9. Elias D, Debaere T, Roche A, Bonvallot S, Lasser P: Preoperative selective portal vein embolization are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 1998; 45:170-177.
10. Azoulay D, Castaing D, Krissat J, Small A, Marin HG, Lemoine A, Emile JF, Bismuth H: Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232:665-672.
11. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoire A, Bismuth H: Resection of nonresectable liver metastases from calorectal cancer after percutaneous portal vein embalization. Ann Surg 2000; 231:480-486.
12. Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H: Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg 2000; 87:879-882.
13. Liver Cancer Study Group of Japan: Classification of Primary Liver Cancer: (First English Edition) Tokyo: Kanehara & Co, Ltd, 1997.
14. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H: Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21:434-439.
15. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S: Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999; 29:1099-1105.
16. Tanaka H, Hirohashi K, Kubo S, Ikebe T, Tsukamoto T, Hamba H, Shuto T, Wakasa K, Kinoshita H: Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization. J Gastroenteral 1999; 34:100-104.
17. Miyagawa S, Kawasaki S, Noike T, Nomura K, Kobayashi A, Shimada R, Imamura H: Liver regeneration after extended right hemihepatectomy in patients with hilar or diffuse bile duct carcinoma. Hepatogastroenterology 1999; 46:364-368.
18. Johnston DG, Johnson GA, Alberti KG, Millward-Sadler GH, Mitchell J, Wright R: Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats: effects of insulin therapy. Eur J Clin Invest 1986; 16:384-390.
19. Yamada T, Yamamoto M, Ozawa K, Honjo I: Insulin requirements for hepatic regeneration following hepatectomy. Ann Surg 1977; 185:35-42.
20. Mori K, Ozawa K, Kiuchi T, Takada Y, Yamaguchi T, Sadamoto T, Shimahara Y, Kobayashi N, Yamaoka Y, Kumada K: Insulinopenia as a risk factor in hepatectomy and its resolution by intraportal insulin administration. Am J Surg 1991; 162:43-49.
21. Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, Hamajima N: Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg 1993; 17:250-255.
22. Suzuki H, Iyomasa S, Nimura Y, Yoshida S: Internal biliary drainage, unlike external drainage, does not suppress the regeneration of cholestatic rat liver after partial hepatectomy. Hepatology 1994; 20:1318-1322.
23. Saiki S, Chijiiwa K, Komura M, Yamaguchi K, Kuroki S, Tanaka M: Preoperative internal biliary drainage is superior to external biliary drainage in liver regeneration and function after hepatectomy in obstructive jaundiced rats. Ann Surg 1999; 230:655-662.
24. Matsumura H, Moriyama M, Goto I, Tanaka N, Okubo, H, Arakawa Y: Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C: a study of 527 patients at one establishment. J Viral Hepat 2000; 7:268-275.
25. Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H: Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 1998; 13:907-913.
26. Kaushansky K: Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995; 74:521-525.
27. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S, Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986; 166:139-150.
28. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T: Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987; 224:311-316.
29. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M: Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology 1998; 28:756-760.
30. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Inoue K, Imamura M: Hepatocyte growth factor supply accelerates compensatory hypertrophy caused by portal branch ligation in normal and jaundiced rats. J Surg Res 1999; 85:115-119.
31. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio K, Kurokawa K: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993; 18:1443-1449.
32. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K, Yuasa S: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem Tokyo 1995; 117:1105-1112.
33. 4-induced acute liver injury in rats. Biochem Biophys Res Commun 1996; 218:1-5.
34. Kaido T, Yamaoka S, Seto S, Tanaka J, Funaki N, Nakamura T, Imamura M: Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett 1997; 411:378-382.
35. Seto S, Kaido T, Yamaoka S, Yoshikawa A, Arii S, Nakamura T, Niwano M, Imamura M: Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 1998; 80:194-199.
36. Yoshikawa A, Kaido T, Seto S, Yamaoka S, Imamura M: Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats. J Surg Res 1998; 78:54-59.
37. Kaido T, Seto S, Yamaoka S, Yoshikawa A, Imamura M: Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res 1998; 74:173-178.
38. Takeda Y, Arii S, Kaido T, Niwano M, Moriga T, Mori A, Hanaki K, Gorrin-Rivas MJ, Ishii T, Sato M, Imamura M: Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation 1999; 67:820-828.
39. Matsuda Y, Matsumoto K, Ichida T, Nakamura T: Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem Tokyo 1995; 118:643-649.
40. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5:226-230.
41. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K, Ishii T: The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 2000; 59:681-690.
42. Yamashita K, Matsuoka H, Ochiai T, Matsushita R, Kubuki Y, Suzuki M, Tsubouchi H: Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers. J Gastroenterol Hepatol 2000; 15:83-90.